ANG Lifesciences India Ltd

NSE: ANG · BSE: 540694 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹37.83
Market cap: ₹49.40 Cr
Revenue (annual): ₹92.89 Cr
Net profit (annual): ₹-11.08 Cr
P/E (TTM): -3.7×Sector 47.3×
Promoter holding: 70.60%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 2 Board Meeting Date 2 Price Movement Clarification 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

14 Aug 2026 18:25 IST BSE

Financial Results

ANG Lifesciences India Q1 FY27 Results: Net Loss of ₹4.2 Cr, Loss Widens

ANG Lifesciences India Ltd reported revenue from operations of ₹15.3 Cr (-37.8% YoY) and a net loss of ₹4.2 Cr for Q1 FY27.

Key figure: Net loss ₹4.2 Cr

Open full results → Read the filing ↗

30 May 2026 22:16 IST BSE

Financial Results

ANG Lifesciences India Q4 FY26 Results: Net Loss of ₹1.4 Cr, Loss Narrows

ANG Lifesciences India Ltd reported revenue from operations of ₹23.5 Cr (+39.9% YoY) and a net loss of ₹1.4 Cr for Q4 FY26.

Key figure: Net loss ₹1.4 Cr

Open full results → Read the filing ↗

30 May 2026 22:15 IST BSE

Financial Results

ANG Lifesciences India Financial Results

ANG Lifesciences approved audited standalone and consolidated financial results for FY2026. The board meeting concluded with an unmodified audit opinion from statutory auditors.

Read the filing ↗

7 Apr 2026 16:04 IST BSE

Financial Results

ANG Lifesciences India Q3 FY26 Results: Net Loss of ₹4.7 Cr, Loss Narrows

ANG Lifesciences India Ltd reported a net loss of ₹4.7 Cr for Q3 FY26.

Key figure: Net loss ₹4.7 Cr

Open full results → Read the filing ↗